Exploratory analysis of a prognosis predictive formula for metastatic colorectal cancer treated with chemotherapy.

被引：0
|
作者：
Tanaka, Mamoru
Kusaba, Hitoshi
Mukaide, Satomi
Kishimoto, Junji
Kumagai, Hozumi
Makiyama, Akitaka
Shirakawa, Tsuyoshi
Oda, Hisanobu
Komoda, Masato
Mitsugi, Kenji
Akashi, Koichi
Baba, Eishi
机构：
[1] Kyushu Univ Hosp, Dept Hematol & Oncol, Fukuoka 812, Japan
[2] Kyushu Univ Hosp, Ctr Clin & Translat Res, Fukuoka 812, Japan
[3] Kyushu Univ Hosp, Dept Res & Dev Next Generat Med, Fac Med Sci, Fukuoka 812, Japan
[4] Japan Community Hlth Care Org Kyushu Hosp, Dept Hematol Oncol, Fukuoka, Japan
[5] Natl Hosp Org Kyushu Canc Ctr, Dept Gastrointestinal & Med Oncol, Fukuoka, Japan
[6] Kyushu Natl Canc Ctr, Dept Gastrointestinal & Med Oncol, Fukuoka, Japan
[7] Natl Hosp Org Kyushu Med Ctr, Dept Med Oncol, Fukuoka, Japan
[8] Hamanomachi Hosp, Dept Med Oncol, Fukuoka, Japan
[9] Kyushu Univ, Fac Med Sci, Dept Comprehens Clin Oncol, Fukuoka 812, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 03期
关键词：
D O I：
10.1200/jco.2015.33.3_suppl.757
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
757
引用
收藏
页数：1
相关论文
共 50 条
  • [1] EXPLORATORY ANALYSIS OF A PROGNOSIS PREDICTIVE MODEL FOR METASTATIC COLORECTAL CANCER TREATED WITH CHEMOTHERAPY
    Tanaka, Mamoru
    Kumagai, Hozumi
    Kishimoto, Junji
    Mukaide, Satomi
    Oda, Hisanobu
    Mitsugi, Kenji
    Makiyama, Akitaka
    Komoda, Masato
    Kusaba, Hitoshi
    Baba, Eishi
    ANNALS OF ONCOLOGY, 2014, 25
  • [2] Predictive value of VEGF gene polymorphisms in metastatic colorectal cancer patients treated with a bevacizumab-based chemotherapy.
    Ulivi, Paola
    Marisi, Giorgia
    Scarpi, Emanuela
    Passardi, Alessandro
    Ragazzini, Angela
    Frassineti, Giovanni Luca
    Zoli, Wainer
    Valgiusti, Martina
    Nanni, Oriana
    Calistri, Daniele
    Casacci, Fabio
    Amadori, Dino
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [3] Complex carbohydrates as a predictive marker in metastatic colorectal cancer (mCRC) cancer patients treated with a vascular endothelial growth factor (VEGF) inhibitor and chemotherapy.
    Martin, Petra
    Fennelly, David William
    Rudd, Pauline
    O'Donoghue, Diarmuid
    Sheahan, Kieran
    Nolan, Blathnaid
    O'Sullivan, Jacintha
    Stockmann, Henning
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [4] Sex as a predictive factor in metastatic colorectal cancer treated with bevacizumab containing chemotherapy
    Jeong, Jae-Heon
    Baek, Sun Kyung
    Chae, Jung Min
    Lee, Gil Yeon
    Park, Sun Jin
    Kim, Si-Young
    Yoon, Hwi Joong
    Cho, Kyung Sam
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [5] Prognostic and predictive factors in patients with metastatic or recurrent cervical cancer treated with platinum-based chemotherapy.
    Sofia Karageorgopoulou
    Ioannis D. Kostakis
    Maria Gazouli
    Sonia Markaki
    Marios Papadimitriou
    Evangelos Bournakis
    Meletios-Athanassios Dimopoulos
    Christos A Papadimitriou
    BMC Cancer, 17
  • [6] Association of MGMT-535G>T polymorphism with prognosis for patients with metastatic colorectal cancer treated with oxaliplatin-based chemotherapy.
    Chae, Y.
    Kim, J.
    Sohn, S.
    Kang, B.
    Ryoo, H.
    Bae, S.
    Choi, G.
    Baek, J.
    Kim, Y.
    Cho, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [7] Exploratory biomarker analysis in avelumab-treated patients with metastatic Merkel cell carcinoma progressed after chemotherapy.
    Shapiro, Irina
    Grote, Hans Juergen
    D'Urso, Vittorio
    von Heydebreck, Anja
    Mahnke, Lisa
    Kaufman, Howard
    Nghiem, Paul
    Cal, Ti
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [8] Chemotherapy efficacy in metastatic colorectal cancer (mCRC) patients treated with adjuvant or first-line FOLFOX-based chemotherapy.
    Samalin, Emmanuelle
    Tien Tuan Nguyen
    Thezenas, Simon
    Portales, Fabienne
    Mazard, Thibault
    Gourgou, Sophie
    Assenat, Eric
    Ychou, Marc
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [9] Defective mismatch repair (dMMR) status as a predictive biomarker in Chinese patients (pts) with metastatic colorectal cancer (mCRC) treated with bevacizumab (BV) plus chemotherapy.
    Ling, Jiayu
    Chen, Dianke
    Zhang, Jianwei
    Zhong, Lixing
    Cai, Yue
    Deng, Yanhong
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [10] Exploratory analysis of microRNAs as predictive markers of benefit from cetuximab in metastatic colorectal cancer
    Kurland, John F.
    Horak, Christine E.
    Whitney, Gena S.
    Malone, Daniel P.
    Khambata-Ford, Shirin
    CANCER RESEARCH, 2011, 71
12345